Back
Editas Medicine Vs. Adverum Biotechnologies Industry Stock Comparison
Sell
22
EDIT
Editas Medicine
Last Price:
$1.33
Seasonality Move:
-11.28%
Sell
29
ADVM
Adverum Biotechnologies
Last Price:
$4.73
Seasonality Move:
20.2%
Sell
22
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
-
The current Editas Medicine [EDIT] share price is $1.31. The Score for EDIT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
EDIT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Adverum Biotechnologies (ADVM)
is a Sell
Is Adverum Biotechnologies a Buy, Sell or Hold?
-
The current Adverum Biotechnologies [ADVM] share price is $4.74. The Score for ADVM is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
ADVM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $1.31Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight selling pressure.
ADVM Stock Price Chart
What is Adverum Biotechnologies's stock price today?
-
The Adverum Biotechnologies share price today is $4.74Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADVM is experiencing slight selling pressure.
EDIT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.36 | Sell |
Relative Strength Index (14 RSI): | 23.89 | Sell |
Chaikin Money Flow: | -1676224 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.63 - 2.43) | Sell |
Bollinger Bands (100): | (2.37 - 4.05) | Sell |
ADVM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.56 | Sell |
Relative Strength Index (14 RSI): | 26.02 | Sell |
Chaikin Money Flow: | -19445 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.3 - 6.52) | Sell |
Bollinger Bands (100): | (6.15 - 7.75) | Sell |
EDIT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.54 | Sell |
20-day SMA: | 1.92 | Sell |
50-day SMA: | 2.6 | Sell |
200-day SMA: | 4.58 | Sell |
8-day EMA: | 1.53 | Sell |
20-day EMA: | 1.88 | Sell |
50-day EMA: | 2.47 | Sell |
200-day EMA: | 4.44 | Sell |
ADVM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.22 | Sell |
20-day SMA: | 5.79 | Sell |
50-day SMA: | 6.88 | Sell |
200-day SMA: | 8.49 | Sell |
8-day EMA: | 5.14 | Sell |
20-day EMA: | 5.71 | Sell |
50-day EMA: | 6.43 | Sell |
200-day EMA: | 8.25 | Sell |
Editas Medicine Earnings Growth & EDIT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $1.18 per share.
Adverum Biotechnologies Earnings Growth & ADVM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.56 per share, and an increase next year of $0.70 per share.
Editas Medicine Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Adverum Biotechnologies Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |